Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases (2021)
- Authors:
- USP affiliated authors: ULRICH, ALEXANDER HENNING - IQ ; GLASER, TALITA - IQ ; GIACOMELLI, ÁGATHA OLIVEIRA - IQ ; PETIZ, LYVIA LINTZMAIER - IQ ; RIBEIRO, DEIDIANE ELISA - IQ
- Unidade: IQ
- DOI: 10.3389/fphar.2021.659097
- Subjects: DOENÇAS NEURODEGENERATIVAS; RECEPTORES; ANTAGONISTAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 12, p. 1-7 art. 659097, 2021
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
GLASER, Talita et al. Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases. Frontiers in Pharmacology, v. 12, p. 1-7 art. 659097, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.659097. Acesso em: 27 dez. 2025. -
APA
Glaser, T., Giacomelli, Á. O., Petiz, L. L., Ribeiro, D. E., Andrejew, R., & Ulrich, H. (2021). Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases. Frontiers in Pharmacology, 12, 1-7 art. 659097. doi:10.3389/fphar.2021.659097 -
NLM
Glaser T, Giacomelli ÁO, Petiz LL, Ribeiro DE, Andrejew R, Ulrich H. Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-7 art. 659097.[citado 2025 dez. 27 ] Available from: https://doi.org/10.3389/fphar.2021.659097 -
Vancouver
Glaser T, Giacomelli ÁO, Petiz LL, Ribeiro DE, Andrejew R, Ulrich H. Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-7 art. 659097.[citado 2025 dez. 27 ] Available from: https://doi.org/10.3389/fphar.2021.659097 - Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease
- The P2X7 receptor: central hub of brain diseases
- Stem cells: principles and applications
- Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires]
- Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases
- ATP and spontaneous calcium oscillations control neural stem cell fate determination in Huntington’s disease: a novel approach for cell clock research
- P2X7 receptor signaling in stress and depression
- P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation
- Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia
- Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease
Informações sobre o DOI: 10.3389/fphar.2021.659097 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3030581.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
